Asthma Comparative Effectiveness Study - Asthma CER
Study identifier:RWE-000015
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A U.S. retrospective database analysis evaluating the comparative effectiveness of budesonide/formoterol combination (BFC) and fluticasone propionate/salmeterol Combination (FSC) among asthma patients
Medical condition
asthma
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
6086
Study type
Observational
Age
12 Years - 64 Years
Date
Study Start Date: 01 Jun 2012
Primary Completion Date: 01 Jul 2012
Study Completion Date: 01 Sept 2012
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| Symbicort BFC patients new to ICS/LABA combination therapy | - |
| Advair FSC patients new to ICS/LABA combination therapy | - |
